These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28082797)

  • 21. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
    Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
    Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of eurycomanone from cell suspension culture of Eurycoma longifolia.
    Nhan NH; Loc NH
    Pharm Biol; 2017 Dec; 55(1):2234-2239. PubMed ID: 29130786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplasmodial studies of Eurycoma longifolia Jack using the lactate dehydrogenase assay of Plasmodium falciparum.
    Chan KL; Choo CY; Abdullah NR; Ismail Z
    J Ethnopharmacol; 2004 Jun; 92(2-3):223-7. PubMed ID: 15138004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPLC-UV-Based Simultaneous Determination of Canthin-6-One Alkaloids, Quassinoids, and Scopoletin: The Active Ingredients in Eurycoma Longifolia Jack and Eurycoma Harmandiana Pierre, and Their Anti-Inflammatory Activities.
    Chaingam J; Juengwatanatrakul T; Yusakul G; Kanchanapoom T; Putalun W
    J AOAC Int; 2021 Jun; 104(3):802-810. PubMed ID: 33064798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing a validated liquid chromatography-mass spectrometric method for the simultaneous analysis of five bioactive quassinoid markers for the standardization of manufactured batches of Eurycoma longifolia Jack extract as antimalarial medicaments.
    Teh CH; Murugaiyah V; Chan KL
    J Chromatogr A; 2011 Apr; 1218(14):1861-77. PubMed ID: 21367427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update Review on the Anthelmintic Activity of Bitter Gourd,
    Poolperm S; Jiraungkoorskul W
    Pharmacogn Rev; 2017; 11(21):31-34. PubMed ID: 28503051
    [No Abstract]   [Full Text] [Related]  

  • 27. In Vitro and In Silico Analysis of the Anticancer Effects of Eurycomanone and Eurycomalactone from
    Yunos NM; Wahab HA; Al-Thiabat MG; Sallehudin NJ; Jauri MH
    Plants (Basel); 2023 Jul; 12(15):. PubMed ID: 37570981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quassinoids from Eurycoma longifolia.
    Miyake K; Tezuka Y; Awale S; Li F; Kadota S
    J Nat Prod; 2009 Dec; 72(12):2135-40. PubMed ID: 19919052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quassinoids from
    Yunos NM; Al-Thiabat MG; Sallehudin NJ; Wahab HA
    Curr Pharm Biotechnol; 2024; 25(16):2154-2165. PubMed ID: 38425119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro anti-tumor promoting and anti-parasitic activities of the quassinoids from Eurycoma longifolia, a medicinal plant in Southeast Asia.
    Jiwajinda S; Santisopasri V; Murakami A; Sugiyama H; Gasquet M; Riad E; Balansard G; Ohigashi H
    J Ethnopharmacol; 2002 Sep; 82(1):55-8. PubMed ID: 12169407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fingerroot,
    Ongwisespaiboon O; Jiraungkoorskul W
    Pharmacogn Rev; 2017; 11(21):27-30. PubMed ID: 28503050
    [No Abstract]   [Full Text] [Related]  

  • 32. A Systematic Review on Antimicrobial and Antiparasitic Activity of
    Latip MQA; Noor MHM; Ahmad H; Hassim HA; Salleh A; Bejo MH; Zakaria AA
    Biomed Res Int; 2022; 2022():4999797. PubMed ID: 35845951
    [No Abstract]   [Full Text] [Related]  

  • 33.
    Thu HE; Hussain Z; Mohamed IN; Shuid AN
    Curr Drug Targets; 2018; 19(10):1109-1126. PubMed ID: 28721818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase-5 Inhibitory Activity of Canthin-6-One Alkaloids and the Roots of Eurycoma longifolia and Eurycoma harmandiana.
    Choonong R; Chaingam J; Chantakul R; Mukda S; Temkitthawon P; Ingkaninan K; Juengwatanatrakul T; Yusakul G; Kanchanapoom T; Putalun W
    Chem Biodivers; 2022 Jul; 19(7):e202200121. PubMed ID: 35652145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NF-κB inhibitors from Eurycoma longifolia.
    Tran TV; Malainer C; Schwaiger S; Atanasov AG; Heiss EH; Dirsch VM; Stuppner H
    J Nat Prod; 2014 Mar; 77(3):483-8. PubMed ID: 24467387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract.
    Salman SA; Amrah S; Wahab MS; Ismail Z; Ismail R; Yuen KH; Gan SH
    J Clin Pharm Ther; 2010 Dec; 35(6):691-6. PubMed ID: 21054461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the pharmacokinetics of 13α,21-dihydroeurycomanone and eurycomanone exclusively enriched in Eurycoma longifolia extracts and their spermatogenesis enhancement in andrographolide-induced oligospermia in rats.
    Chung WJ; Chan KL; Lee CY
    J Pharm Pharmacol; 2021 Mar; 73(2):161-168. PubMed ID: 33793798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LC-MS/MS-based metabolites of Eurycoma longifolia (Tongkat Ali) in Malaysia (Perak and Pahang).
    Chua LS; Amin NA; Neo JC; Lee TH; Lee CT; Sarmidi MR; Aziz RA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3909-19. PubMed ID: 22119436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute, reproductive toxicity and two-generation teratology studies of a standardized quassinoid-rich extract of Eurycoma longifolia Jack in Sprague-Dawley rats.
    Low BS; Das PK; Chan KL
    Phytother Res; 2014 Jul; 28(7):1022-9. PubMed ID: 24318772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vitro and in vivo anti-cancer activities of a standardized quassinoids composition from Eurycoma longifolia on LNCaP human prostate cancer cells.
    Tong KL; Chan KL; AbuBakar S; Low BS; Ma HQ; Wong PF
    PLoS One; 2015; 10(3):e0121752. PubMed ID: 25826409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.